These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 5491873)

  • 41. [Treatment of cutaneous leishmaniasis with glucantime. Apropos of 9 cases].
    Ramos García AN; Pérez Avila J; Pérez Ramos E; Díaz Hernández A; Ruiz Pérez A
    Rev Cubana Med Trop; 1984; 36(2):151-9. PubMed ID: 6399595
    [No Abstract]   [Full Text] [Related]  

  • 42. Treatment of schistosomiasis caused by S. haematobium.
    VAN BEUKERING JA
    Doc Med Geogr Trop; 1957 Sep; 9(3):259-60. PubMed ID: 13473697
    [No Abstract]   [Full Text] [Related]  

  • 43. [Pluri-focal cutaneous leishmaniasis treated with intralesional glucantime].
    Duperrat B; Puissant A; Fischer R; Badillet G; Mascaro JM
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(2):219-20. PubMed ID: 5914173
    [No Abstract]   [Full Text] [Related]  

  • 44. [Sodium antimony III gluconate in the treatment of schistosomiasis mansoni].
    DA SILVA JR; DIAS CB
    Rev Assoc Med Bras; 1957 May; 3(1):33-6. PubMed ID: 13466236
    [No Abstract]   [Full Text] [Related]  

  • 45. American cutaneous leishmaniasis: disappearance of amastigotes from lesions during antimonial therapy.
    Mayrink W; Raso P; Melo MN; Michalick MS; Magalhães PA; Williams P; da Costa CA; Dias M
    Rev Inst Med Trop Sao Paulo; 1983; 25(6):265-9. PubMed ID: 6672988
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of leishmaniasis (author's transl)].
    Barabe P
    Med Trop (Mars); 1981; 41(6):599-605. PubMed ID: 7339417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Use of the indirect immunofluorescence test in the therapeutic follow-up of cutaneous leishmaniasis americana].
    de Souza WJ; Coutinho SG; Marzochi MC; de Toledo LM; Gottlieb MV
    Mem Inst Oswaldo Cruz; 1982; 77(3):247-53. PubMed ID: 6763131
    [No Abstract]   [Full Text] [Related]  

  • 48. Late cutaneous leishmaniasis.
    Hart M; Livingood CS; Goltz RW; Totonchy M
    Arch Dermatol; 1969 Apr; 99(4):455-8. PubMed ID: 5769330
    [No Abstract]   [Full Text] [Related]  

  • 49. [Cutaneous leishmaniasis].
    Vion B
    Rev Med Suisse Romande; 1989 Jun; 109(6):443-9. PubMed ID: 2547241
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of cutaneous leishmaniasis of acutely necrotizing type with solusurmine].
    Dobrzhanskaia RS
    Vestn Dermatol Venerol; 1966 Oct; 40(10):57-61. PubMed ID: 4232015
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of schistosomiasis in recruits with triostam.
    OMAR H
    Med J Egypt Armed Forces; 1956 Dec; 2(2):30-8. PubMed ID: 13417929
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of cutaneous leishmaniasis in Saudi Arabia.
    Fattah AA; Morsy TA; Ismail MA
    J Egypt Soc Parasitol; 1983 Jun; 13(1):9-17. PubMed ID: 6313824
    [No Abstract]   [Full Text] [Related]  

  • 53. Leishmania tropica infections.
    Long JC
    Arch Dermatol; 1977 Jan; 113(1):108. PubMed ID: 831613
    [No Abstract]   [Full Text] [Related]  

  • 54. The use of Pentostam liposomes in the chemotherapy of experimental leishmaniasis.
    Black CD; Watson GJ; Ward RJ
    Trans R Soc Trop Med Hyg; 1977; 71(6):550-2. PubMed ID: 204085
    [No Abstract]   [Full Text] [Related]  

  • 55. The histopathological and cytological diagnosis of cutaneous leishmaniasis in two cases of leishmania tropica.
    Lagerholm B; Lodin A; Gip L
    Acta Derm Venereol; 1968; 48(6):600-7. PubMed ID: 4185299
    [No Abstract]   [Full Text] [Related]  

  • 56. Cutaneous leishmaniasis in mice: resistance to glucan immunotherapy, either alone or combined with chemotherapy.
    Avila JL; Biondo F; Monzón H; Convit J
    Am J Trop Med Hyg; 1982 Jan; 31(1):53-9. PubMed ID: 7058978
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The fitness of antimony-resistant Leishmania parasites: lessons from the field.
    Ait-Oudhia K; Gazanion E; Oury B; Vergnes B; Sereno D
    Trends Parasitol; 2011 Apr; 27(4):141-2. PubMed ID: 21216196
    [No Abstract]   [Full Text] [Related]  

  • 58. In vitro susceptibility of antimony-resistant Leishmania to alternative drugs.
    Berman JD
    J Infect Dis; 1982 Feb; 145(2):279. PubMed ID: 6274970
    [No Abstract]   [Full Text] [Related]  

  • 59. [Leishmaniasis vegetans and terramycin].
    Pinillos VC; Lovatón AC
    Dermatol Int; 1967; 6(3):165-7. PubMed ID: 5590120
    [No Abstract]   [Full Text] [Related]  

  • 60. Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria.
    Belazzoug S; Neal RA
    Trans R Soc Trop Med Hyg; 1986; 80(4):670-1. PubMed ID: 3544363
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.